Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Accunea

Developing novel point-of-care diagnostic and monitoring technologies for clinical centres

Arctoris

Oxford-based startup revolutionising cancer research by combining robotics and AI

BrainWaveBank

Developing solutions to track cognitive fitness and spot early signs of dementia

Bridge Biotec

Developing novel, safe and effective treatments for serious inflammatory diseases i.e inflammatory bowel disease

Celentyx

Developing novel targeted therapeutic antibodies for immuno-oncology and immune-mediated disease

East Anglia Therapeutics

Have developed, published and patented a new nanoparticle based targeted cancer therapy

EpiCombi Therapeutics

Developed a platform technology that enables the identification of optimised epigenetic-driven drug combinations

Invizius

University of Edinburgh spinout company improving treatment for dialysis patients

Janus Genomics

Providing a platform with machine learning and deep learning tools for new insights on multi-omics data

Kinomica

Providing competitive intelligence to enhance tailored treatment decisions involving anticancer drug therapies

OmniSpirant Therapeutics

Developing inhaled bioengineered exosome therapeutics

Oxford Biomaterials

Platform technology company developing silk-based products